ImmuCell
ICCC
ICCC
19 hedge funds and large institutions have $5.98M invested in ImmuCell in 2017 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$180K | |
| 2 | +$146K | |
| 3 | +$115K | |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$74.6K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$12K |
Top Sellers
| 1 | -$223K | |
| 2 | -$57.3K | |
| 3 | -$56.5K | |
| 4 |
Renaissance Technologies
New York
|
-$37.8K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$14.9K |